Company Filing History:
Years Active: 1993-2007
Title: Innovator Patrick F. Coleman: Pioneering Advances in Medical Diagnostics
Introduction
Patrick F. Coleman, an accomplished inventor based in Edmonds, WA, has made significant contributions to the field of medical diagnostics. With a total of four patents to his name, Coleman has focused his expertise on developing innovative methods for detecting viral infections, particularly in the realm of herpes simplex virus and HIV.
Latest Patents
Two of Coleman's latest patents exemplify his cutting-edge work in immunoassays and synthetic antigens. The first patent, titled "HSV-2 Type-Specific Immunoassays Using Glycoprotein G2 Peptides," addresses the need for type-specific serological diagnosis of HSV-2 infection. This invention includes peptides derived from the glycoprotein G2 of HSV-2, which serve as epitopes for the detection of HSV-2 antibodies, differentiating HSV-2 infections from those caused by HSV-1 and other herpes family viruses.
The second patent involves a "Synthetic Antigen for the Detection of Antibodies Immunoreactive with HIV Virus." This innovation provides novel polypeptides that mimic immunologically significant fragments of AIDS-related viruses. These polypeptides are crucial reagents for determining human exposure to the HIV virus, particularly in screening blood products for safety.
Career Highlights
Throughout his career, Patrick F. Coleman has been associated with prestigious companies such as Bio-Rad Laboratories, Inc. and Beckman Instruments, Inc. His work in these organizations has fostered advancements in medical technology and diagnostics, allowing for early detection and intervention in viral infections.
Collaborations
Coleman has collaborated with notable individuals in his field, including Carol-Ann Cole and Nobuo Monji. These collaborations have contributed to the shared goal of enhancing medical diagnostics and improving patient outcomes.
Conclusion
Patrick F. Coleman's innovative spirit and dedication to improving medical diagnostics through his patents have positioned him as a key figure in the field. His work continues to impact the development of effective diagnostic tools, paving the way for advancements in the detection and treatment of viral infections.